(i) Prospective database () (ii) 52.5–72 Gy in 20–36 F, conventional or 3DCRT (iii) Neoadjuvant (), median duration (5.1 M), concurrent (), adjuvant (), and median duration (11 M)
implantation (110 Gy) followed in 2 M by 50.4 Gy of IMRT in 1.8 Gy/F ()
90 D PTC
90 D PTC
CTCAE
CTCAE
Median 30 M
No
PTC = posttreatment completion, univariate (UV), multivariate (MV), androgen deprivation therapy (ADT), and TRT = throughout radiotherapy. Acute RTOG = Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer acute morbidity rating scale. Late RTOG = Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer late morbidity rating scale. LENT = Late Effects Normal Tissue Task Force scale. SOMA = Subjective, Objective, Management, and Analytic (SOMA) scales. UCLA-PCI = University of California Loss Angeles Prostate Cancer Index. RMH scale = Royal Marsden Hospital scale. EPIC = Expanded Prostate Cancer Index Composite. CTC v2 = Common Toxicity Criteria v2.0. CTCAE V3 = Common Terminology Criteria for Adverse Events v3.0. QLQ-C30 = EORTC QLQ-C30 quality of life questionnaire. QLQ-PR25 = EORTC QLQ-PR25 quality of life questionnaire. WHO = World Health Organization criteria.